WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. WebMar 20, 2024 · The latest price target for . Cytokinetics (NASDAQ: CYTK) was reported by JP Morgan on March 20, 2024.The analyst firm set a price target for $52.00 expecting CYTK to rise to within 12 months (a ...
CYTK Earnings Date 2024 Cytokinetics Earnings Forecast
WebCYTK - Cytokinetics Inc Stock quote - CNNMoney.com Markets Tech Media Success Video Cytokinetics Inc (NASDAQ:CYTK) Real-Time Quotes 35.31 BATS BZX Real-Time Price As of 1:28pm ET -0.84 / -2.32%... WebClose price at the end of the last trading day (Wednesday, 1st Mar 2024) of the CYTK stock was $43.11. This is 0.577% less than the trading day before Tuesday, 28th Feb 2024. During the day the stock fluctuated 2.40% from a day low at $42.86 to a day high of $43.89. how to store tulip bulbs in florida
Cytokinetics (CYTK) Analysts Prediction, Stock Forecast & Price …
WebMar 2, 2024 · Find out the current price target and stock forecast for Cytokinetics ... the average price target for Cytokinetics comes to $61.40. The forecasts range from a low of $47.00 to a high of $80.00 ... WebApr 6, 2024 · Cytokinetics initiated with buy rating, $60 price target at Truist Dec. 20, 2024 at 7:41 a.m. ET by Steve Gelsi Cytokinetics started at buy with $80 stock price target at … WebFeb 28, 2024 · Cytokinetics Stock Up 0.4 %. Shares of CYTK opened at $42.98 on Tuesday. Cytokinetics, Incorporated has a 52 week low of $33.10 and a 52 week high of $55.80. The firm has a market cap of $4.07 billion, a P/E ratio of -13.60 and a beta of 0.90. The firm's 50-day simple moving average is $43.66 and its 200 day simple moving … reader\u0027s choice book awards